While the role of lipid rafts in other diseases, such as antiphospholipid syndrome (APS), has been explored [51], an open question is whether they directly regulate RAGE activity and how metformin’s effects on these membrane domains may influence RAGE-mediated pathways. This evidence concerns the gene AGER and autoimmune polyendocrinopathy.